In clinical development, the choice of analytical tools affects, auditability, validation, and how easily teams can meet regulatory expectations. For decades, SAS has anchored statistical programming in trials, while R and Python have expanded what teams can do across analysis and data workflows.
This article outlines how SAS vs R vs Python differs in practice, where each fits, and how to decide what works best for a given team.
These three tools are often grouped together because they can all analyse data, but they are built on different design principles.
SAS is a commercial analytics platform designed for structured analysis and reporting in regulated environments. It provides predefined procedures and a controlled system for consistent outputs.
R is an open-source programming language focused on statistical computing. Its functionality is extended through packages, allowing teams to tailor analyses to specific needs.
Python is a general-purpose programming language with strong support for data processing and machine learning. It sits within a broader software ecosystem and is often used beyond statistical analysis alone.
They overlap in capability, but differ in how analysis is built, governed, and deployed.
Each tool tends to align with different parts of the clinical development workflow.
SAS in regulated delivery
SAS remains closely tied to SDTM and ADaM dataset generation, tables, listings, and figures (TFLs), and submission-ready outputs. Its long-standing use has created established processes across sponsors, CROs, and regulators, with workflows built around its validated and traceable environment.
R in statistical exploration and emerging submission work
R is commonly used for exploratory data analysis, advanced statistical modelling, data visualisation, and reporting. It is also increasingly used in submission contexts. Industry-led initiatives have demonstrated how clinical workflows can be built in R, including ADaM datasets and TFLs prepared for regulatory-facing pilot work or review. In practice, this still requires clear governance, controlled packages, documented versions, and reproducible outputs.
Python in broader data workflows
Python typically supports data engineering and integration, automation and pipelines, and machine learning and AI. Its strength lies in connecting clinical data with wider systems rather than replacing established statistical programming tools.
In practice, tool selection is shaped by operational constraints rather than theoretical capability.
Cost and access
SAS requires commercial licensing, which can influence adoption. R and Python are open-source and freely available.
Support and ecosystem
SAS provides formal vendor support and controlled updates. R and Python rely on community ecosystems, which are broader but less centralised.
Flexibility and extensibility
R and Python allow rapid adoption of new methods through packages and libraries. SAS provides a more fixed set of procedures, supporting consistency but limiting experimentation.
Collaboration and workflows
SAS workflows tend to be standardised and predictable. R workflows vary depending on package choices. Python integrates well with software engineering practices such as version control and APIs. Across all three, collaboration depends on how well teams manage code review, documentation, version control, and handover between programmers, statisticians, data managers, and technology teams.
Learning curve
R and Python require programming fluency. SAS is often easier to standardise in teams focused on repeatable reporting.
The distinction between SAS and R is technical and conceptual. SAS follows a procedural model using predefined steps such as DATA steps and PROCs, supporting repeatable workflows. R uses a function and package-driven approach, where analyses are built through composable code.
This leads to a practical trade-off: SAS supports standardisation, while R supports flexibility and method development.
In regulated environments, the focus is on whether results can be trusted, reproduced, and clearly explained. Key considerations include:
SAS has historically aligned with these expectations due to its controlled environment and long-standing use in submissions. However, regulators such as the FDA do not mandate specific software. Instead, they assess the integrity of the analysis and the clarity of documentation.
This shift has opened the door to open-source tools, provided teams implement appropriate validation and governance. That governance should be aligned with current expectations for good clinical practice, data integrity, privacy, and electronic records, including principles reflected in ICH E6(R3), ICH E8(R1), 21 CFR Part 11, GDPR, MHRA expectations, and CDISC standards where relevant.
This is often framed as a direct replacement question, but in practice adoption is incremental.
R can support many statistical tasks and is now used in some regulatory submissions. Industry pilot programmes have demonstrated end-to-end workflows in R, including datasets and outputs prepared for regulatory-facing review or feedback.
However, full replacement depends on internal validation strategies, organisational governance, team capability and infrastructure, and control of packages, environments, code review, and reproducible execution.
Most organisations therefore adopt R alongside SAS rather than replacing it entirely.
Yes, and this is increasingly the standard approach. Modern workflows often use SAS for submission-ready outputs, R for statistical modelling and visualisation, and Python for data engineering and automation.
There is also growing interoperability, including the ability to run R and Python within SAS environments. For example, some environments support controlled use of R or Python from within SAS workflows, although suitability still depends on validation, licensing, infrastructure, and standard operating procedures.
This allows teams to align each tool with the part of the workflow it supports best. Emerging approaches such as containers, Dataset-JSON, and web-based execution models may also influence future workflows, but they should be treated as evolving capabilities rather than default practice.
The answer depends on role and context. SAS remains important for clinical programming roles focused on regulatory deliverables. R is widely used in biostatistics and research-driven analysis. Python is valuable where data science, automation, or system integration is involved.
R and Python are sometimes presented as direct competitors, but their roles differ.
R remains widely used for statistical modelling and analysis in clinical research. Python has broader adoption in machine learning, engineering, and data pipelines.
In practice, they are used for different purposes, and often within the same workflow rather than as substitutes.
There is no single answer to the SAS vs R vs Python question. The right choice depends on regulatory context, team capability, and the type of work being delivered.
SAS supports consistency and established submission workflows. R enables flexible, statistics-focused analysis. Python extends capabilities into automation and data engineering.
Most clinical teams now work across more than one language. The key decision is how to combine them in a way that supports both compliance and efficiency.
It depends on your role. SAS is widely used for regulatory programming, while R is common in statistical analysis.
R can support many similar tasks, but full replacement depends on validation, governance, and organisational readiness. For many teams, coexistence is more realistic than a complete switch.
No. SAS is a proprietary platform with predefined procedures, while R is an open-source programming language built around packages.
All three support data analysis, but SAS is more standardised, while R and Python are more flexible.
No. Python is growing, but R remains widely used in statistical work. They are typically used alongside each other.
Quanticate’s statistical programming team can support clinical trial teams with validated, traceable, and efficient programming across SAS, R, and Python workflows. From CDISC datasets and TFLs to automation, reproducible reporting, and submission-ready outputs, our experts help sponsors choose and apply the right tools for their study needs. To discuss how we can support your clinical trial, request a consultation below.